Director of Translational Medicine, Oracle’s Health Sciences
Sean Sigmon is a Director of Translational Medicine for Oracle’s Health Sciences business focused on Personalized Medicine. Previously, Sean was VP of Sales and Business Development at Translational Software, a leading Pharmacogenetic (PGx) Reporting company. Prior to Translational, he was a global marketing manager with Microsoft’s Health Solutions Group, a senior manager with Philips’ Healthcare market intelligence group and spent more than 10 years with Boehringer Ingelheim. Throughout his career he’s helped executives and clinicians understand and embrace new therapies, devices, software and ways of working.
Sean holds a BA in Economics from University of Washington and a MBA from Seattle University.
Session: Producing Clinically Actionable Reports
A discussion of current thinking of how to manage the challenges of producing a report a clinician can use and a molecular lab can be proud of. The session will focus on the data integration challenges associated with genomic instruments, Electronic Health Records (EHR), Tumor Board Reviews, state of the art clinical curation processes and much more. Thought leaders that are actively providing cutting edge services in the Precision Medicine market today will participate in a lively discussion about how best to incorporate all of the new information available to researchers, clinicians and patients in a scalable and cost effective way. Don’t miss this one.
Scaling & Enhancing Precision Medicine (PM) Reporting
Making good decisions using genomic data is a team sport. Clinicians, counselors, and patients need to understand the challenges at hand to make life altering decisions. Bench researchers and informatisists need to explore the potential learnings from these “once in a lifetime” tests while lab administrators and life science companies need to demonstrate the broad utility of their nascent tests and therapies. Scaling PM requires integrated technologies that enable actionable reporting and data sharing for the appropriate stakeholders.